Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Ordinary Shares, $0.0005 par value
-
Shares outstanding
-
25.1M
-
Number of holders
-
7
-
Total 13F shares, excl. options
-
73.9K
-
Shares change
-
+40.3K
-
Total reported value, excl. options
-
$489K
-
Value change
-
+$270K
-
Number of buys
-
4
-
Number of sells
-
-4
-
Price
-
$6.49
Significant Holders of Meihua International Medical Technologies Co., Ltd. - Ordinary Shares, $0.0005 par value (MHUA) as of Q1 2023
8 filings reported holding MHUA - Meihua International Medical Technologies Co., Ltd. - Ordinary Shares, $0.0005 par value as of Q1 2023.
Meihua International Medical Technologies Co., Ltd. - Ordinary Shares, $0.0005 par value (MHUA) has 7 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 73.9K shares
of 25.1M outstanding shares and own 0.29% of the company stock.
Largest 8 shareholders include CITADEL ADVISORS LLC (39.1K shares), Invesco Ltd. (27.8K shares), Tower Research Capital LLC (TRC) (4.76K shares), MORGAN STANLEY (1.1K shares), JPMORGAN CHASE & CO (1.04K shares), UBS Group AG (68 shares), ADVISOR GROUP HOLDINGS, INC. (1 shares), and CITIGROUP INC (0 shares).
This table shows the top 7 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.